Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis
Shuai Shao, Chengjuan Chen, Gaona Shi, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107880-107880
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
Lieselotte Vande Walle, Mohamed Lamkanfi
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 43-66
Closed Access | Times Cited: 111
Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis‐related NLRP3 pathway
Shuang Song, Ruoyi Guo, Arshad Mehmood, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 3, pp. 422-434
Open Access | Times Cited: 66
Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
Yueran Cui, Haiyang Yu, Zhongqi Bu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 41
The pathogenesis and potential therapeutic targets in sepsis
Wendan Zhang, Honghong Jiang, Gaosong Wu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 33
Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears
Mubarak Alruwaili, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Neurochemical Research (2023) Vol. 48, Iss. 11, pp. 3255-3269
Open Access | Times Cited: 26
Inflammasomes cross-talk with lymphocytes to connect the innate and adaptive immune response
Hongliang Zhang, Jie Gao, Yujie Tang, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 181-193
Open Access | Times Cited: 23
NLRP3: a new therapeutic target in alcoholic liver disease
Subhashini Brahadeeswaran, Tiasha Dasgupta, Venkatraman Manickam, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
NLRP3 inflammasome and its role in autoimmune diseases: A promising therapeutic target
Wenxuan Ren, Ying Sun, Lei Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116679-116679
Open Access | Times Cited: 14
Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis
Xiaxin Zhu, Chi Zhang, Shuyan Feng, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Pyroptosis: a new insight into intestinal inflammation and cancer
Limin Chao, Wenjing Zhang, Yuchao Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Augmented microglial endoplasmic reticulum-mitochondria contacts mediate depression-like behavior in mice induced by chronic social defeat stress
Jiarui Zhang, Shi-Yu Shen, Meng-Ying Zhai, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Role of fenofibrate in multiple sclerosis
Ahmad Abulaban, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Therapeutic Potential of Targeting the NLRP3 Inflammasome in Rheumatoid Arthritis
Jie Gao, Hongliang Zhang, Yanyan Yang, et al.
Inflammation (2023) Vol. 46, Iss. 3, pp. 835-852
Closed Access | Times Cited: 20
Estrogen plays an important role by influencing the NLRP3 inflammasome
Wanglin Dong, Qianwen Peng, Z. Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115554-115554
Open Access | Times Cited: 19
Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases
Haoyu Wang, Xi Lin, Guan-gen Huang, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 8, pp. 1687-1700
Closed Access | Times Cited: 18
Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity
Annalisa Marcuzzi, E. Melloni, Giorgio Zauli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11241-11241
Open Access | Times Cited: 33
Protective effect of ginsenoside Rh2 against Toxoplasma gondii infection-induced neuronal injury through binding TgCDPK1 and NLRP3 to inhibit microglial NLRP3 inflammasome signaling pathway
Guang‐Nan Jin, Jing‐Mei Lu, Hui‐Wen Lan, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109176-109176
Closed Access | Times Cited: 22
Unmasking the NLRP3 inflammasome in dendritic cells as a potential therapeutic target for autoimmunity, cancer, and infectious conditions
Shiva Alipour, Amirhossein Mardi, Neda Shajari, et al.
Life Sciences (2024) Vol. 348, pp. 122686-122686
Closed Access | Times Cited: 4
The Role of NLRP3 Inflammatory Bodies in Cerebral Hemorrhage and Progress in Targeted Therapy
Chunmei Wei, Shiyu Luo, Guo Jun Liu
Journal of Modern Biology and Drug Discovery (2025) Vol. 4, pp. 2-2
Closed Access
Polysaccharide extract from Isatidis Radix inhibits multiple inflammasomes activation and alleviate gouty arthritis
Lutong Ren, Qiang Li, Hui Li, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 8, pp. 3295-3312
Closed Access | Times Cited: 17
NLRP3 inflammasome involves in the pathophysiology of sepsis-induced myocardial dysfunction by multiple mechanisms
Hongwei Zhang, Jian Liao, Litong Jin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115497-115497
Open Access | Times Cited: 10
Discovery of a Covalent Inhibitor of Pro-Caspase-1 Zymogen Blocking NLRP3 Inflammasome Activation and Pyroptosis
Dongyi Cao, Ruiying Xi, Hongye Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 15873-15891
Closed Access | Times Cited: 3
Gastrodenol suppresses NLRP3/GSDMD mediated pyroptosis and ameliorates inflammatory diseases
Peipei Chen, Yunshu Wang, Huaiping Tang, et al.
Cellular Immunology (2024) Vol. 405-406, pp. 104888-104888
Closed Access | Times Cited: 3
Does Pyroptosis Play a Role in Inflammasome-Related Disorders?
Jiajia Zhang, Stefan Wirtz
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10453-10453
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top